BridgeBio Pharma: Q3 Earnings Insights

BridgeBio Pharma BBIO reported its Q3 earnings results on Thursday, November 3, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

BridgeBio Pharma beat estimated earnings by 6.06%, reporting an EPS of $-0.93 versus an estimate of $-0.99.

Revenue was down $2.01 million from the same period last year.

Last quarter the company missed on EPS by $0.18 which was followed by a 12.12% increase in the share price the next day.

Here's a look at BridgeBio Pharma's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	-0.63	-1.11	-0.87	-0.90
EPS Actual	-0.81	-1.19	-1.01	-1.06
Revenue Estimate	16.07M	4.69M	21.58M	17.36M
Revenue Actual	73.75M	1.69M	12.89M	2.34M

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for BridgeBio Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar